Daily Archives: March 17, 2023
MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer
March 17th, 2023 Cancer, Cancer treatment in China, CAR T-Cell therapy, Ovarian CancerMarch 2023: Brief Summary: The goal of this clinical trial is to study the feasibility and efficacy of anti-MESO antigen receptors CAR T-cell therapy for relapsed and refractory epithelial ovarian cancer. Detailed Description: Pri.... Read More
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren’s Syndrome
March 17th, 2023 Cancer treatment in China, CAR T-Cell therapyDetailed Description: Autoimmune diseases only show local pathological damage, but more often systemic lesions. If not diagnosed and treated in time or poorly controlled, a risk of disability or even death as the course of the disease progre.... Read More
Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
March 17th, 2023 Brain Tumor, Cancer, CAR T-Cell therapy, Clinical trials, Drugs, GlioblastomaMarch 2023: Study Type : Interventional (Clinical Trial)Estimated Enrollment : 30 participantsAllocation: N/AIntervention Model: Sequential AssignmentIntervention Model Description: a "3+3" design is used to determine Maximum Tolerated Dose.... Read More
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed Refractory Non-Hodgkin Lymphoma
March 17th, 2023 UncategorizedDetailed Description: This is a single-center, single-arm, open-label study. After meeting the eligibility criteria and enrolling on the trial, patients will undergo leukapheresis for collection of autologous lymphocytes. Once cells have been.... Read More
Clinical trial for the April CAR-T Cell therapy for patients with BCMA/TACI positive relapsed and/or refractory multiple myeloma
March 17th, 2023 Blood cancer, Cancer, CAR T-Cell therapy, MyelomaBrief Summary: A study of APRIL CAR-T cells therapy for patients with BCMA/TACI positive relapsed and/or refractory multiple myeloma Detailed Description: This is a single arm, open-label, single-center study. This study is indic.... Read More
